317 related articles for article (PubMed ID: 11896107)
21. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.
Pandya KJ; Raubertas RF; Flynn PJ; Hynes HE; Rosenbluth RJ; Kirshner JJ; Pierce HI; Dragalin V; Morrow GR
Ann Intern Med; 2000 May; 132(10):788-93. PubMed ID: 10819701
[TBL] [Abstract][Full Text] [Related]
22. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study.
Barton DL; Schroeder KCF; Banerjee T; Wolf S; Keith TZ; Elkins G
Menopause; 2017 Jul; 24(7):774-782. PubMed ID: 28266949
[TBL] [Abstract][Full Text] [Related]
24. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis.
Loprinzi CL; Sloan J; Stearns V; Slack R; Iyengar M; Diekmann B; Kimmick G; Lovato J; Gordon P; Pandya K; Guttuso T; Barton D; Novotny P
J Clin Oncol; 2009 Jun; 27(17):2831-7. PubMed ID: 19332723
[TBL] [Abstract][Full Text] [Related]
25. Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration.
Loprinzi CL; Diekmann B; Novotny PJ; Stearns V; Sloan JA
Menopause; 2009; 16(5):883-7. PubMed ID: 19295449
[TBL] [Abstract][Full Text] [Related]
26. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations.
L'Espérance S; Frenette S; Dionne A; Dionne JY;
Support Care Cancer; 2013 May; 21(5):1461-74. PubMed ID: 23435567
[TBL] [Abstract][Full Text] [Related]
28. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1.
Loprinzi CL; Qin R; Balcueva EP; Flynn KA; Rowland KM; Graham DL; Erwin NK; Dakhil SR; Jurgens DJ; Burger KN
J Clin Oncol; 2010 Feb; 28(4):641-7. PubMed ID: 19901102
[TBL] [Abstract][Full Text] [Related]
29. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.
Tice JA; Ettinger B; Ensrud K; Wallace R; Blackwell T; Cummings SR
JAMA; 2003 Jul; 290(2):207-14. PubMed ID: 12851275
[TBL] [Abstract][Full Text] [Related]
30. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.
Jacobson JS; Troxel AB; Evans J; Klaus L; Vahdat L; Kinne D; Lo KM; Moore A; Rosenman PJ; Kaufman EL; Neugut AI; Grann VR
J Clin Oncol; 2001 May; 19(10):2739-45. PubMed ID: 11352967
[TBL] [Abstract][Full Text] [Related]
31. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.
Barton DL; LaVasseur BI; Sloan JA; Stawis AN; Flynn KA; Dyar M; Johnson DB; Atherton PJ; Diekmann B; Loprinzi CL
J Clin Oncol; 2010 Jul; 28(20):3278-83. PubMed ID: 20498389
[TBL] [Abstract][Full Text] [Related]
32. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.
Stearns V; Slack R; Greep N; Henry-Tilman R; Osborne M; Bunnell C; Ullmer L; Gallagher A; Cullen J; Gehan E; Hayes DF; Isaacs C
J Clin Oncol; 2005 Oct; 23(28):6919-30. PubMed ID: 16192581
[TBL] [Abstract][Full Text] [Related]
33. Pilot evaluation of black cohosh for the treatment of hot flashes in women.
Pockaj BA; Loprinzi CL; Sloan JA; Novotny PJ; Barton DL; Hagenmaier A; Zhang H; Lambert GH; Reeser KA; Wisbey JA
Cancer Invest; 2004; 22(4):515-21. PubMed ID: 15565808
[TBL] [Abstract][Full Text] [Related]
34. Treatment of menopausal hot flashes with 5-hydroxytryptophan.
Freedman RR
Maturitas; 2010 Apr; 65(4):383-5. PubMed ID: 20031347
[TBL] [Abstract][Full Text] [Related]
35. Hot-flashes in breast cancer survivors: effectiveness of low-dosage fluoxetine. A pilot study.
Mariani L; Quattrini M; Atlante M; Galati M; Barbati A; Giannarelli D
J Exp Clin Cancer Res; 2005 Sep; 24(3):373-8. PubMed ID: 16270523
[TBL] [Abstract][Full Text] [Related]
36. Hot flashes in breast cancer survivors: Frequency, severity and impact.
Chang HY; Jotwani AC; Lai YH; Jensen MP; Syrjala KL; Fann JR; Gralow J
Breast; 2016 Jun; 27():116-21. PubMed ID: 27065357
[TBL] [Abstract][Full Text] [Related]
37. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
Pinkerton JV; Constantine G; Hwang E; Cheng RF;
Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
[TBL] [Abstract][Full Text] [Related]
38. Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase II trial.
Nuñez GR; Pinczowski H; Zanellato R; Tateyama L; Schindler F; Fonseca F; Del Giglio A
J Pain Symptom Manage; 2013 Jun; 45(6):969-79. PubMed ID: 23017618
[TBL] [Abstract][Full Text] [Related]
39. Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women.
Moyad MA
Urology; 2002 Apr; 59(4 Suppl 1):20-33. PubMed ID: 11937433
[TBL] [Abstract][Full Text] [Related]
40. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5.
Loprinzi CL; Kugler JW; Barton DL; Dueck AC; Tschetter LK; Nelimark RA; Balcueva EP; Burger KN; Novotny PJ; Carlson MD; Duane SF; Corso SW; Johnson DB; Jaslowski AJ
J Clin Oncol; 2007 Jan; 25(3):308-12. PubMed ID: 17146104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
